Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
Nieuwe richtlijn Topicale en systemische behandeling van ziekte van Sjögren
jan 2025 | Sjögren